Related Experiment Videos
Rosmaricine derivatives as potential antitumoral agents
A Boido1, F Savelli, F Sparatore
1Istituto di Scienze Farmaceutiche, Università di Genova.
Abstract:
A group of N-(alkylaminoacyl)-O,O-dimethylrosmaricines was prepared and, together with a set of rosmaricine derivatives previously described by us, evaluated for activity against lymphocytic leukemia P 388. Only one compound exhibited a borderline activity, while all the others were inactive.